Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015–2020

Africa is responsible for two‐thirds of the global total of new HIV infections. South Africa, Nigeria, Mozambique, Uganda, Tanzania, Zambia, Zimbabwe, Kenya, Malawi, and Ethiopia were responsible for 80% of HIV cases in Africa in 2014 according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). This study assesses antiretroviral coverage strategies implemented by these countries after the initiation of the “Fast‐Track strategy to end the AIDS epidemic by 2030.” Data reported in this review were obtained from different e‐bibliographic including PubMed, Google Scholar, and Research Gate. Key terms were “Antiretroviral therapy,” “Antiretroviral treatment,” “HIV treatment,” “HIV medication,” “HIV/AIDS therapy,” “HIV/AIDS treatment” + each of the countries listed earlier. We also extracted data on antiretroviral therapy (ART) coverage from the UNAIDS database. About 50 papers published from 2015 to 2021 met the inclusion criteria. All 10 countries have experienced an increase in ART coverage from 2015 to 2020 with an average of 47.6% increment. Nigeria recorded the highest increase in the rate of ART coverage (72% increase) while Ethiopia had the least (30%). New strategies adopted to increase ART coverage and retention in most countries were community‐based models and the use of mobile health technology rather than clinic‐based. These strategies focus on promoting task shifting, door‐to‐door access to HIV services, and a long‐term supply of antiretroviral medications. Most of these strategies are still in the piloting stage. However, some new strategies and frameworks have been adopted nationwide in countries like Mozambique, Tanzania, Zambia, Zimbabwe, Kenya, and Malawi. Identified challenges include lack of funding, inadequate testing and surveillance services, poor digital penetration, and cultural/religious beliefs. The adoption of community‐based and digital health strategies could have contributed to increased ART coverage and retention. African countries should facilitate nationwide scaling of ART coverage strategies to attain the 95–95–95 goal by 2030.

[1]  S. Odafe,et al.  Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge , 2021, PloS one.

[2]  R. King,et al.  Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study , 2021, JMIR mHealth and uHealth.

[3]  G. Kayode,et al.  Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study , 2021, PloS one.

[4]  M. Fox,et al.  Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis , 2021, PLoS ONE.

[5]  I. Jani,et al.  Inpatient Point-of-Care HIV Early Infant Diagnosis in Mozambique to Improve Case Identification and Linkage to Antiretroviral Therapy , 2021, Global Health: Science and Practice.

[6]  R. Hayes,et al.  A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study , 2021, Trials.

[7]  S. Pals,et al.  High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019. , 2020, Journal of acquired immune deficiency syndromes.

[8]  J. Baeten,et al.  Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial , 2020, The Lancet. Global health.

[9]  N. Jewell,et al.  Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. , 2020, The lancet. HIV.

[10]  A. Misganaw,et al.  Progress towards the 2020 fast track HIV/AIDS reduction targets across ages in Ethiopia as compared to neighboring countries using global burden of diseases 2017 data , 2020, BMC Public Health.

[11]  M. Fox,et al.  Differentiated HIV care in South Africa: the effect of fast‐track treatment initiation counselling on ART initiation and viral suppression as partial results of an impact evaluation on the impact of a package of services to improve HIV treatment adherence , 2019, Journal of the International AIDS Society.

[12]  A. L. Nyondo-Mipando,et al.  Factors influencing adherence to antiretroviral treatment among adults accessing care from private health facilities in Malawi , 2019, BMC Public Health.

[13]  L. Berrie,et al.  Monitoring viral load for the last mile: what will it cost? , 2019, Journal of the International AIDS Society.

[14]  R. Zulliger,et al.  Mozambique’s Community Antiretroviral Therapy Support Group Program: The Role of Social Relationships in Facilitating HIV/AIDS Treatment Retention , 2019, AIDS and Behavior.

[15]  E. Szumilin,et al.  Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi , 2019, Journal of the International AIDS Society.

[16]  M. Fox,et al.  Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa , 2019, PLoS medicine.

[17]  B. Sartorius,et al.  Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe , 2019, AIDS.

[18]  Muddukrishna Badamane Sathyanarayana,et al.  President’s Emergency Plan for AIDS Relief , 2018, Systematic Reviews in Pharmacy.

[19]  S. McCoy,et al.  The heterogeneous effect of short-term transfers for improving ART adherence among HIV-infected Tanzanian adults , 2018, AIDS care.

[20]  E. Okechukwu,et al.  Bridging the HIV treatment gap in Nigeria: examining community antiretroviral treatment models , 2018, Journal of the International AIDS Society.

[21]  S. Arinze-Onyia,et al.  Do peer support groups have an effect on medication adherence? A study among people living with HIV/AIDS in Enugu State, Nigeria , 2018 .

[22]  N. Ford,et al.  Identifying models of HIV care and treatment service delivery in Tanzania, Uganda, and Zambia using cluster analysis and Delphi survey , 2017, BMC Health Services Research.

[23]  C. Boeke,et al.  Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial , 2017, Journal of acquired immune deficiency syndromes.

[24]  S. Bautista-Arredondo,et al.  Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania , 2017, PloS one.

[25]  R. Noor,et al.  The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania , 2017, BMC Health Services Research.

[26]  N. Jewell,et al.  Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania , 2017, AIDS.

[27]  A. Crampin,et al.  Identifying gaps in HIV service delivery across the diagnosis-to-treatment cascade: findings from health facility surveys in six sub-Saharan countries , 2017, Journal of the International AIDS Society.

[28]  Kebba Jobarteh,et al.  Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care , 2016, PloS one.

[29]  John Ashmore,et al.  Adherence clubs for long‐term provision of antiretroviral therapy: cost‐effectiveness and access analysis from Khayelitsha, South Africa , 2016, Tropical medicine & international health : TM & IH.

[30]  F. Meinck,et al.  Achieving equity in HIV-treatment outcomes: can social protection improve adolescent ART-adherence in South Africa? , 2016, AIDS care.

[31]  D. Bangsberg,et al.  The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda , 2016, AIDS.

[32]  Adeyemi Abayomi Awofala,et al.  HIV epidemiology in Nigeria , 2016, Saudi journal of biological sciences.

[33]  K. Torpey,et al.  The Value of Support Group Participation in Influencing Adherence to Antiretroviral Treatment among People Living with Human Immunodeficiency Virus (HIV) , 2015 .

[34]  T. Hallett,et al.  Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study , 2014, The Lancet.

[35]  Dorothy Bray,et al.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.

[36]  P. Mbabazi,et al.  MINISTRY OF HEALTH, UGANDA , 2019 .

[37]  B. Walker,et al.  Antiretroviral therapy in early HIV infection. , 2013, The New England journal of medicine.

[38]  Anthony Appiah,et al.  Encyclopedia of Africa , 2010 .